16 August, 2018 in Business Economics, Commentary / 0 Comments Eliminate Pharmaceutical Rebates to Improve Patient Welfare
07 August, 2018 in Business Economics, Commentary, Healthcare / 0 Comments Reforming Medicare’s Competitive Bidding Program To Improve Health And Lower Costs
31 July, 2018 in Blog, Business Economics, California / 0 Comments California’s Public Pension Systems Are Not Immune from Financial Consequences
26 July, 2018 in Healthcare, Study / 0 Comments NEW STUDY: Medicare Competitive Bidding Process Should Be Reformed
12 July, 2018 in Business Economics, Commentary, Healthcare / 0 Comments It’s Generics Not PBMs That Keep Pharmaceuticals Affordable
12 June, 2018 in Business Economics, Commentary / 0 Comments Tariffs Are A Clear and Present Danger To The U.S. Economy
05 June, 2018 in Business Economics, Commentary / 0 Comments Embracing Competition To Empower Biosimilars
05 June, 2018 in Business Economics, Healthcare, Study / 0 Comments New Study: Patients, Employers and Taxpayers Could Save Significantly if Barriers to Biosimilars Removed
31 May, 2018 in Blog, Business Economics / 0 Comments The Anti-Growth Tariffs Are a Clear and Present Danger to Our Future Economic Prosperity
